We are live on ! Find out more
MRKR icon

Marker Therapeutics
MRKR

32 hedge funds and large institutions have $3.09M invested in Marker Therapeutics in 2025 Q3 according to their latest regulatory filings, with 8 funds opening new positions, 9 increasing their positions, 3 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

200% more repeat investments, than reductions

Existing positions increased: 9 | Existing positions reduced: 3

14% more first-time investments, than exits

New positions opened: 8 | Existing positions closed: 7

3% more funds holding

Funds holding: 31 → 32 (+1)

3.44% less ownership

Funds ownership: 30.14% → 26.71% (-3.4%)

41% less capital invested

Capital invested by funds: $5.22M → $3.09M (-$2.13M)

Holders
32
Holders Change
+1
Holders Change %
+3.23%
% of All Funds
0.42%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
8
Increased
9
Reduced
3
Closed
7
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Osaic Holdings
Osaic Holdings
Arizona
+$75.9K
2
TSS
Two Sigma Securities
New York
+$58.8K
3
Renaissance Technologies
Renaissance Technologies
New York
+$45.4K
4
Two Sigma Investments
Two Sigma Investments
New York
+$45.1K
5
VF
Virtu Financial
New York
+$35K

Top Sellers

Rank Fund Capital Flow
1
Alyeska Investment Group
Alyeska Investment Group
Illinois
-$326K
2
Jane Street
Jane Street
New York
-$33.4K
3
Dimensional Fund Advisors
Dimensional Fund Advisors
Texas
-$24.3K
4
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$19K
5
LPL Financial
LPL Financial
California
-$18.5K
Name Holding Trade Value Shares
Change 		Change in
Stake
NMC
1
NEA Management Company
Maryland
$1.45M – – –
BOCH
2
Blue Owl Capital Holdings
New York
$495K – – –
ACM
3
Aisling Capital Management
New York
$290K – – –
Vanguard Group
4
Vanguard Group
Pennsylvania
$268K +$30.2K +24,436 +9%
Renaissance Technologies
5
Renaissance Technologies
New York
$94.8K +$45.4K +36,808 +53%
Geode Capital Management
6
Geode Capital Management
Massachusetts
$86K +$677 +548 +0.6%
Osaic Holdings
7
Osaic Holdings
Arizona
$74.2K +$75.9K +61,504 +314%
LPL Financial
8
LPL Financial
California
$52.4K -$18.5K -15,000 -20%
TGIA
9
Torrey Growth & Income Advisors
California
$46.4K +$64.2K +51,984 New
TSS
10
Two Sigma Securities
New York
$42.5K +$58.8K +47,603 New
Two Sigma Investments
11
Two Sigma Investments
New York
$32.6K +$45.1K +36,540 New
I
12
INVST
Indiana
$25.9K +$6.91K +5,600 +24%
VF
13
Virtu Financial
New York
$25K +$35K +28,329 New
XT
14
XTX Topco
Cayman Islands
$19.4K +$26.9K +21,772 New
State Street
15
State Street
Massachusetts
$18.7K – – –
Creative Planning
16
Creative Planning
Kansas
$15.5K – – –
MAA
17
Matrix Asset Advisors
New York
$13.4K – – –
Northern Trust
18
Northern Trust
Illinois
$9.69K – – –
ATPW
19
Ashton Thomas Private Wealth
Arizona
$8.93K +$12.3K +10,000 New
Citigroup
20
Citigroup
New York
$8.28K +$11.5K +9,276 New
UBS Group
21
UBS Group
Switzerland
$5.17K +$5.18K +4,194 +262%
Bank of America
22
Bank of America
North Carolina
$1K +$11 +9 +0.8%
BlackRock
23
BlackRock
New York
$885 – – –
Morgan Stanley
24
Morgan Stanley
New York
$412 +$74 +60 +15%
Wells Fargo
25
Wells Fargo
California
$216 +$12 +10 +4%
1
2

MRKR Hedge Fund Activity: Q3 2025 in Review

32 of the 7,622 institutional investors tracked by Wall St. Rank reported a position in Marker Therapeutics (MRKR) for Q3 2025, worth a combined $3.09M — down 41% from $5.22M a quarter earlier.

Buyers outnumbered sellers: 8 funds opened new MRKR positions and 7 closed out — a net gain of 1 holder — while 9 added to existing stakes and 3 trimmed.

The largest buyer was Osaic Holdings, adding an estimated $75.9K. The largest seller was Alyeska Investment Group, exiting entirely with an estimated $326K sold.

  • 32 institutional investors held Marker Therapeutics (MRKR) as of Q3 2025, up from 31 in Q2 2025.
  • Funds reported $3.09M of Marker Therapeutics stock for Q3 2025, down 41% quarter-over-quarter.
  • 8 funds opened new Marker Therapeutics positions in Q3 2025 and 7 closed out, a net change of +1 holder.
  • The largest Marker Therapeutics buyer in Q3 2025 was Osaic Holdings, an estimated $75.9K added.
  • The largest Marker Therapeutics seller in Q3 2025 was Alyeska Investment Group, an estimated $326K sold.

Based on aggregated 13F filings for Q3 2025.